Advisor Group Holdings, Inc. Medi Wound Ltd. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.35 - $2.24 $371 - $616	-275 Reduced 0.57%	47,605 $66,000
Q2 2022 Aug 10, 2022	BUY	$1.33 - $2.35 $57,190 - $101,050	43,000 Added 881.15%	47,880 $89,000
Q1 2022 May 04, 2022	BUY	$1.86 - $3.24 $6,138 - $10,692	3,300 Added 208.86%	4,880 $1.28 Million
Q1 2021 May 13, 2021	BUY	$3.77 - $6.05 $384 - $617	102 Added 6.9%	1,580 $8,000
Q4 2020 Feb 10, 2021	BUY	$3.12 - $4.08 $1,248 - $1,632	400 Added 37.11%	1,478 $5,000

Q1 2020 May 18, 2020	BUY	$1.57 - $3.1 $1,692 - $3,341	1,078 New	1,078 $1,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $789M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.